Timothy Iveson

机构：University Hospital Southampton NHS Foundation Trust, University of Southampton · ORCID：0000-0002-4681-2712

发表论文 189 篇 · 总被引 31474 次 · h-index 51

代表论文

• Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study (2023 · Cancer Cell · 被引 264)
• Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer (2023 · Nature Medicine · 被引 84)
• JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors (2024 · Journal of Experimental & Clinical Cancer Research · 被引 46)
• NEOPRISM-CRC: Neoadjuvant pembrolizumab stratified to tumour mutation burden for high risk stage 2 or stage 3 deficient-MMR/MSI-high colorectal cancer. (2024 · Journal of Clinical Oncology · 被引 35)
• Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer (2022 · JAMA Oncology · 被引 31)
• Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies (2024 · Journal of Clinical Oncology · 被引 28)